Efficacy of glutathione for the treatment of nonalcoholic fatty liver disease: An open-label, single-arm, multicenter, pilot study
For adaptive immunity, it restores the balance of T-cell subsets, promoting regulatory Treg differentiation, inhibiting pathogenic Th17 and autoreactive CD8 + T cell activation, and regulating Tfh cell function
[DOI] [PubMed] [Google Scholar] 174.Drmic D., Samara M., Vidovic T., Malekinusic D., Antunovic M., Vrdoljak B., Ruzman J., Milkovic Perisa M., Horvat Pavlov K., Jeyakumar J., et al
BPC-157 is not FDA-approved and is used off-label based on preclinical evidence and clinical experience
Not for human use, consumption, or therapeutic applications